Latest AI and machine learning research in hypertension for healthcare professionals.
AIMS: Particulate matter ≤2.5μm (PM2.5) air pollution is a leading global environmental risk factor. We investigated the impact of PM2.5 on cardiovascular risk with lifetime genetic predisposition to low-density lipoprotein cholesterol (LDL-C) and systolic blood pressure (SBP). METHODS: We conducted a Mendelian Randomization (MR) study of participants from the UK Biobank study (n = 412,446) over 1...
OBJECTIVES: To identify the biological, behavioural, and socio-demographic determinants of childhood and adolescent obesity and evaluate how their relative importance shifts across age strata using an Explainable Artificial Intelligence (XAI) approach. STUDY DESIGN: A cross-sectional analysis of a large-scale, multi-country pooled database. METHODS: Data from 9660 participants (aged 5-17 years) fr...
AIMS: To validate behavioural subtypes among young and middle-aged hypertensive patients using latent class analysis (LCA) and assess their generaliza...
BackgroundThe systemic, metabolic, lifestyle factors have established associations with Alzheimer's disease (AD) through epidemiologic and AD-specific...
PURPOSE: To develop a deep learning model based on nnU-Net for automated segmentation of all perigastric veins on contrast-enhanced CT images in patie...
Ischemic stroke puts great health burden in public. However, the diagnosis is based on head CT or MRI scanning. We aim to develop classifier models to...
Cardiovascular diseases are among the leading causes of global mortality and morbidity, underscoring the need for accurate and explainable predictive ...
BACKGROUND: Heart failure (HF) is a clinical syndrome characterized by impaired cardiac diastolic and systolic function due to structural or functiona...
BACKGROUNDS: Haematoma expansion (HE) is a significant factor in poor outcomes following intracerebral haemorrhage (ICH). Studies have suggested that ...
BACKGROUND: Artificial Intelligence (AI) is transforming personalized medicine, yet its efficacy constitutes a dynamic factor in the field of health a...
AIMS: Heart failure (HF), a major global health challenge, affects millions worldwide and poses substantial healthcare and economic burdens. It is est...
BACKGROUND: Cardiac amyloidosis (CA) is an under-recognized cause of left-ventricular hypertrophy (LVH) that is often misclassified as hypertrophic ca...
BACKGROUND: Ferroptosis plays a significant role in pulmonary arterial hypertension (PAH), although its underlying mechanisms and key pathogenic genes...
BACKGROUND: Early identification of individuals at risk for hypertension is essential for effective cardiovascular disease. Physiological and activity...
OBJECTIVE: The utilization of artificial intelligence-based chatbots in the healthcare field is increasingly prevalent. Nonetheless, the quality of re...
BACKGROUND: Abdominal obesity (AO) significantly contributes to cardiometabolic diseases and poses an increasing public health challenge. Composite li...
BACKGROUND: Congenital heart disease (CHD), one of the most common birth defects, poses challenges to preoperative risk stratification due to its anat...
BACKGROUND AND OBJECTIVE: Continuous monitoring of blood pressure (BP) and hemodynamic parameters such as peripheral resistance (R) and arterial compl...
BACKGROUND: Postoperative cerebrovascular events, including transient ischemic attacks, infarctions, and hemorrhages, remain a significant concern in ...
PURPOSE OF REVIEW: Right ventricular size and function are vital to risk stratification in pulmonary hypertension, valvular disease, and congenital he...